Cologne, November 2025         Dear Colleagues,         Preparations for the 14th International Symposium on Hodgkin Lymphoma (ISHL14) are well underway, and we are pleased to share initial updates on key topics.             The treatment of advanced cHL will be a major topic at ISHL14 again. Follow-up analyses of the landmark GHSG HD21 and SWOG S1826 studies will be presented very soon at this year's ASH Annual meeting. The 3-year data of the SWOG S1826 study confirm the superiority of N-AVD in comparison with BV-AVD across all age and risk groups. Patients aged older than 60 years appear to benefit most from the regimen. The 3-year PFS rates for all patients were 91% with N-AVD as compared to 82% with BV-AVD.         In the final analysis of the HD21 study, the superiority of BrECADD over escalated BEACOPP could be confirmed at 5 years. The PFS rates were 93.6% with BrECADD and 90.6% with escalated BEACOPP. Patients with a negative interim PET after 2 treatment cycles had a particularly pronounced PFS benefit when treated with BrECADD. In relapsed cHL, novel data on ASCT-free salvage treatment will be presented and discussed.             We warmly invite physicians, researchers, and healthcare professionals to save the date for this flagship event in the field of Hodgkin lymphoma. Further details will follow.             📍 Cologne, Germany – Gürzenich Hall Conference Center 📅 October 03–05, 2026         ADD TO CALENDAR             In the meantime, please visit our homepage.         Take care and best regards,         Peter Borchmann, MD, Symposium Chairman Paul J. Bröckelmann, MD, Symposium Co-Chair Dennis Eichenauer, MD, Symposium Co-Chair Justin Ferdinandus, MD, Symposium Co-Chair         Please do not reply directly to this message. If you would like more information on the 14ᵗʰ International Symposium on Hogkin Lymphoma, or have additional questions please contact Gabriele Hanke (info@hodgkinsymposium.org).     Please add enews@hodgkinsymposium.org to your address book to prevent spam filters from blocking these E-Mails.     14ᵗʰ International Symposium on Hodgkin Lymphoma Prof. Peter Borchmann, MD German Hodgkin Study Group (GHSG) Gleueler Str. 269-273 50937 Cologne     Tel. +49 (0)221 478 88159 Fax +49 (0)221 478 88188     E-Mail: info@hodgkinsymposium.org     For more information please click here.